Cargando…
Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China
OBJECTIVE: To assess the potential benefit of chidamide maintenance therapy after induction treatment in peripheral T-cell lymphoma (PTCL). MATERIALS AND METHODS: The clinical data of 48 transplantation-ineligible patients with different PTCL subtypes who received continuous chidamide treatment afte...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209709/ https://www.ncbi.nlm.nih.gov/pubmed/35747802 http://dx.doi.org/10.3389/fonc.2022.875469 |